Stage IIB Skin Melanoma: Clinical Trials

2 trials for Stage IIB Skin Melanoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Stage IIB Skin Melanoma: new trials by email Literature Review of Stage IIB Skin Melanoma trials Research Report on Stage IIB Skin Melanoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Laboratory Biomarker Analysis, Pharmacological Study - Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma
Phase 1CompletedRoswell Park Cancer Institute182012-03-012016-10-04
Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery
gp100:209-217(210M) Peptide Vaccine, HPV 16 E7:12-20 Peptide Vaccine, Laboratory Biomarker Analysis - Recurrent Melanoma, Stage IA Skin Melanoma
Phase 1CompletedNational Cancer Institute (NCI)302002-10-012015-01-26

Narrower conditions

Melanoma (2)  ·  Astrocytoma (1)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Renal Cell (1)  ·  Colorectal Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Glioblastoma (1)  ·  Lung Neoplasms (1)  ·  Oligodendroglioma (1)  ·  Ovarian Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Sarcoma (1)  ·  Stomach Neoplasms (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neuroectodermal Tumors (2)  ·  Neuroendocrine Tumors (2)  ·  Nevi and Melanomas (2)  ·  Skin Diseases (2)  ·  Skin Neoplasms (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Adenocarcinoma (1)  ·  Adnexal Diseases (1)  ·  Brain Diseases (1)  ·  Breast Diseases (1)

Interventions

Peptides (1)  ·  Protein Subunit Vaccines (1)  ·  Sirolimus (1)

Sponsors

National Cancer Institute (NCI) (1)  ·  Roswell Park Cancer Institute (1)

Countries

United States (2)

Top investigators

Kunle Odunsi (1)  ·  Walter Urba (1)

Results publications

PMID 40132910

NIH funding

P30CA016056 (1), R01CA158318 (1), R21CA099265 (1)